RECURRENT LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Clinical trials for RECURRENT LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo takes aim at Tough-to-Treat lung cancer
Disease control OngoingThis study is testing whether a drug called cabozantinib, alone or combined with an immunotherapy drug (nivolumab), works better than standard chemotherapy for people with a specific type of advanced lung cancer that has worsened after initial treatment. It involves about 117 par…
Matched conditions: RECURRENT LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 00:35 UTC
-
New pill targets 'Undruggable' cancer mutation in advanced lung cancer
Disease control OngoingThis study is testing an experimental pill called AMG 510 for people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12C. The pill is designed to block this specific mutation, which can drive cancer growth, in patients whose cancer has wor…
Matched conditions: RECURRENT LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC